Canada - English - Health Canada

pfizer canada ulc - neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a; neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b - suspension - 60mcg; 60mcg - neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a 60mcg; neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b 60mcg - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - neisseria meningitidis group c capsular polysaccharide protein conjugate - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - neisseria meningitidis group c strain c11 capsular polysaccharide tetanus toxoid conjugate; haemophilus influenzae type b polysaccharide tetanus toxoid conjugate - powder and solvent for solution for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - neisseria meningitidis group y capsular polysaccharide protein conjugate; neisseria meningitidis group w135 capsular polysaccharide protein conjugate; neisseria meningitidis group a capsular polysaccharide protein conjugate; neisseria meningitidis group c capsular polysaccharide protein conjugate - powder and solvent for solution for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - neisseria meningitidis serogroup b fhbp subfamily b fusion protein; neisseria meningitidis serogroup b fhbp subfamily a fusion protein - suspension for injection

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - neisseria meningitidis serogroup b recombinant lp2086 subfamily a protein; neisseria meningitidis serogroup b recombinant lp2086 subfamily b protein - injection, suspension - neisseria meningitidis serogroup b recombinant lp2086 subfamily a protein 0.06 mg/0.5ml; neisseria meningitidis serogroup b recombinant lp2086 subfamily b protein 0.06 mg/0.5ml

Australia - English - Department of Health (Therapeutic Goods Administration)

integrated sciences pty ltd - ct793 - neisseria ivds - allplex ng & dr assay is a qualitative in vitro diagnostic test for single or multiple detection of n. gonorrhoeae (ng) and the mutation of a2059g and c2611t in the 23s rrna gene responsible for azithromycin resistance in n. gonorrhoeae (ng), and s91f in the gyrase a responsible for ciprofloxacin resistance in n. gonorrhoeae (ng)

Canada - English - Health Canada

sanofi pasteur limited - meningococcal group a polysaccharide-tetanus toxoid conjugate; meningococcal group c polysaccharide-tetanus toxoid conjugate; meningococcal group y polysaccharide-tetanus toxoid conjugate; meningococcal group w polysaccharide-tetanus toxoid conjugate; tetanus toxoid - solution - 10mcg; 10mcg; 10mcg; 10mcg; 55mcg - meningococcal group a polysaccharide-tetanus toxoid conjugate 10mcg; meningococcal group c polysaccharide-tetanus toxoid conjugate 10mcg; meningococcal group y polysaccharide-tetanus toxoid conjugate 10mcg; meningococcal group w polysaccharide-tetanus toxoid conjugate 10mcg; tetanus toxoid 55mcg - vaccines

Canada - English - Health Canada

merck canada inc - haemophilus influenzae type b-prp; neisseria meningitidis outer membrane protein complex - suspension - 7.5mcg; 125mcg - haemophilus influenzae type b-prp 7.5mcg; neisseria meningitidis outer membrane protein complex 125mcg - vaccines

European Union - English - EMA (European Medicines Agency)

gsk vaccines s.r.l. - outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254), recombinant neisseria meningitidis group b fhbp fusion protein, recombinant neisseria meningitidis group b nada protein, recombinant neisseria meningitidis group b nhba fusion protein - meningitis, meningococcal - meningococcal vaccines - active immunisation against invasive disease caused by neisseria meningitidis serogroup-b strains.,